People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Biotechnology, Other Health Care, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Peptilogics, Inc. | — | Biotechnology | Series B | $40.9M | $1.2B | 2017 |
| CytoAgents, Inc. | — | Other Health Care | Series A | $13.1M | $51.1M | 2021 |
| C360 Technologies, Inc. | — | Software / Tech | Seed | $6.7M | $54.3M | 2016 |
| Angler Labs Inc. | — | Software / Tech | Seed | $6.5M | $30.8M | 2021 |
Catherine Mott at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Catherine Mott on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Friedman | 1 | 9 |
| Keith Bank | 1 | 8 |
| Wayne Kimmel | 1 | 6 |
| Jason Camm | 1 | 5 |
| Dietrich Stephan | 1 | 4 |
| James Jones | 1 | 4 |
| Stephan Dietrich | 1 | 4 |
| STANLEY MARKS | 1 | 4 |
| William Frederick | 1 | 3 |
| Saied Seghatoleslami | 1 | 2 |
| Nicholas Wilson | 1 | 2 |
| Catherine V. Mott | 1 | 2 |
| Stefan Roever | 1 | 2 |
| Joseph Tomko | 1 | 1 |
| Joesph Tomko | 1 | 1 |
| Henry Clement | 1 | 1 |
| Louis Chemi | 1 | 1 |
| Henry V. Gnad | 1 | 1 |
| Keith V. Bank | 1 | 1 |
| Louis V. Chemi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.